← All trials
NCT06823947
Phase 1Interventional
Includes initial studies to determine the metabolism and pharmacologic actions of drugs in humans, the side effects associated with increasing doses, and to gain early evidence of effectiveness; may include healthy participants and/or patients.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Apr 3, 2025
- Primary completion
- Mar 31, 2027
- Completion date
- Mar 31, 2027
- First posted
- Feb 12, 2025
- Last posted
- May 4, 2025
- Enrollment
- 144
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Kyowa Hakko KirinLead sponsor
- Kyowa Hakko KirinOfficial
Drugs studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.